In the early days of the COVID-19 pandemic, XpresCheck established COVID-19 testing facilities in airports across the United States. Over the course of 3+ years, we tested more than 200,000 people. As the spread of COVID-19 slowed, and travel restrictions were lifted, we transitioned our efforts to the US CDC Traveler-Based Genomic Surveillance (TGS) Program.

XpresCheck, in collaboration with the Centers for Disease Control and Prevention (CDC), is now performing bio surveillance at U.S. airports across the country.

We test 6,000+ travelers who arrive in the United States from 135 different countries approximately 1,400 flights every week for COVID-19 and various multi pathogens. Our mission has always been to help keep people safe and protected.